Furthermore,FAK/RhoA signaling can act as downstream effectors of EphA2 for selling tumor progression in non-metastatic RCC cells
Duxberry et al. showed that EphA2 siRNA significantly suppressed FAK phosphorylation as effectively as resistance to apoptosis or mobile invasion in human pancreatic adenocarcinoma cells . Hence, the stage of…